Human Technopole: a new building for scientific research
Milan, 3 April 2020 – Ten floors high, over 16.500 square meters exclusively dedicated to research laboratories and 3.000 square meters of terraces and green areas: a snapshot of the project for the new Human Technopole building, Italy’s research institute for life sciences based at the heart of MIND Milano Innovation District. The building which aims to be modern as well as welcoming, will be the main headquarters of scientific laboratories and the centre of Human Technopole’s campus.
The name of the designer who won the international competition for the design of the building and the campus was announced today by Human Technopole Foundation and Arexpo: the winner is Piuarch, a firm based in Milan which has contributed to many major redevelopment projects in the city, including the Mecenate District and the area of Porta Nuova.
An investment of up to 94.5 million euros is planned for the construction of the new building.
The Human Technopole Campus includes three existing buildings, Palazzo Italia the iconic Milan EXPO 2015 pavilion, a North Pavilion and a South Pavilion and will cover an overall area of over 11.000 square meters. The project describes how the different buildings will be interconnected as well as how connections with external areas will be developed.
The new building will rise within the area of the campus and is expected to be built in 1.100 consecutive days, equivalent to about three years. It will have an overall surface of 35.000 square meters and at its highest point will be 61 meters high. It will host biochemistry and molecular biology laboratories, cutting edge scientific technology including light microscopy, space for an extension of HT’s Cryo-EM facility as well as 800 workstations for researchers. In addition, large common areas, meeting rooms and classrooms for events and trainings will be available.
Read the full press release here.
Share:
You could also like:
-
Two ERC-funded projects to search for tumours’ weaknesses
Human Technopole has once again been awarded by Europe’s prestigious public body for funding of scientific research conducted within the European Union, the European Research Council (ERC), for two projects on the origin of tumours, their evolution and the development of resistance to therapies. The two studies could contribute to the identification of new anti-cancer targeted […]
-
COVID-19: How SARS‑CoV‑2 Enters Human Cells
A study by the University of Padua and Human Technopole, together with the University of Milan and the European Institute of Oncology, published in Cell Reports Medicine, reveals that SARS-CoV-2, the virus that causes COVID-19, binds the RAGE receptor present on the surface of specific human immune cells to penetrate them and pathologically alter their function. This study also shows how the involvement of RAGE, previously known only in the context of other pathophysiological conditions, such as obesity and diabetes, is implicated in the degree of severity with which COVID-19 can manifest.
-
Italy joins the iCARE4CVD consortium
The Human Technopole and Mario Negri institute for Pharmacological Research are among 33 leading international partners who have joined forces to better understand cardiovascular diseases and optimise future prevention and treatment.
-
Study tour “Austrian Life Science Innovation Ecosystem” in Vienna
The Human Technopole Centre for Innovation and Technology Transfer (CITT) continues its international promotion activities by learning about foreign innovation ecosystems. From 28 to 30 November 2023, CITT is organising a study tour to meet the leading players in basic and applied research within the Austrian ecosystem, with the support of the Italian Embassy in Vienna and the Italian Trade Agency.
-
Annotating human genes: where do we stand now?
In a perspective article published in Nature, Piero Carninci and colleagues discuss the status of human gene annotation and how high-throughput RNA sequencing technologies have accelerated the discovery of non-coding RNA genes with unknown functions and will promote the completion of the human gene catalogue.